A case of central diabetes insipidus due to neurophysin II gene abnormality diagnosed based on a family history of nocturnal enuresis.


Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
28 Jan 2022
Historique:
pubmed: 22 9 2021
medline: 5 4 2022
entrez: 21 9 2021
Statut: ppublish

Résumé

The etiology of central diabetes insipidus (DI) is classified into (1) idiopathic, (2) familial, and (3) secondary. Of these, familial central diabetes insipidus shows an autosomal dominant inheritance. We herein report a case in which this disease was diagnosed based on a family history of nocturnal enuresis. A 40-year-old man had had symptoms of polydipsia, polyuria and nocturia since childhood and found that his daughter had the same symptoms. Despite reaching nine years old, his daughter's nocturnal enuresis still had not improved, resulting in her consulting a pediatrician. She was suspected of having familial neurohypophyseal diabetes insipidus (FNDI) based on her family history and was referred along with her father for a detailed examination and treatment. A hypertonic saline load test (HSLT) to evaluate the arginine vasopressin (AVP) reaction was performed in both the proband and his daughter. The results showed no increase in AVP levels in response to high plasma osmolality. The water deprivation test (WDT) revealed he was suffering from partial DI. Based on the above findings and considering the possibility of familial central diabetes insipidus, we performed a gene mutation analysis of AVP-neurophysin II (NPII). Both the father and daughter had an exon 2 abnormality in this gene (c232_234delGAG; pGlu78del), and this gene mutation is known to cause NPII protein abnormality, abolishing the function of AVP as a carrier protein. This case was considered to have provided an opportunity to understand the role of an NPII gene abnormality in familial central diabetes insipidus.

Identifiants

pubmed: 34544934
doi: 10.1507/endocrj.EJ21-0187
doi:

Substances chimiques

Neurophysins 0
Arginine Vasopressin 113-79-1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-100

Auteurs

Lucia Sugawara (L)

Department of Endocrinology and Metabolism, Omihachiman Community Medical Center, Omihachiman, Shiga 523-0082, Japan.
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2092, Japan.

Takaaki Nakamura (T)

Department of Endocrinology and Metabolism, Omihachiman Community Medical Center, Omihachiman, Shiga 523-0082, Japan.

Yoshitaka Ishizuka (Y)

Department of Endocrinology and Metabolism, Omihachiman Community Medical Center, Omihachiman, Shiga 523-0082, Japan.

Hiroshi Maegawa (H)

Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520-2092, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH